GlassScriptPhysician profile
Marissa Donatelle
NPI 1962012625
$3,095.48
in general payments reported to CMS, 2019-2025
20 companies · $1,876 in 2025
The $1,876 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.17 · 2023: $321 · 2024: $818 · 2025: $1,876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713 · Education: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,712.82 |
| Education | $302.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,154.70 | 2023-2025 | Watchman Flx, Farapulse, Avvigo Guidance System |
| Medtronic, INC. | $467.43 | 2023-2025 | Resolute Onyx, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Bayer Healthcare Pharmaceuticals INC. | $181.41 | 2022-2025 | |
| Abbott Laboratories | $179.95 | 2024-2025 | Ensite, Ampere, Workmate Claris |
| Actelion Pharmaceuticals US, INC. | $176.86 | 2025 | Opsumit, Uptravi |
| Chiesi USA, INC. | $155.52 | 2024 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $153.69 | 2024-2025 | Wainua, Andexxa |
| Amgen INC. | $121.49 | 2023-2025 | Repatha, Repatha |
| Lexicon Pharmaceuticals, INC. | $116.95 | 2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $71.98 | 2022-2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $65.08 | 2024-2025 | |
| Abiomed | $64.16 | 2024-2025 | Impella |
| Terumo Medical Corporation | $33.41 | 2023 | Angio-Seal, Tr Band, Heartrail |
| Biotronik INC. | $27.48 | 2023 | Renamic Neo |
| Cleerly, INC. | $25.00 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.09 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.74 | 2024 | Xarelto |
| Ucb, INC. | $20.00 | 2023 | Cimzia |
| Exact Sciences Corporation | $19.15 | 2023 | Cologuard Collection Kit |
| Angiodynamics, INC. | $17.39 | 2025 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marissa Donatelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.